Exedrol (Exemestane) Usage:
Prescribed to therapy:
- post-menopausal women diagnosed with hormone-receptor-positive, begin-stage breast tumor after they`ve taken tamoxifen for 2 to 3 years to diminish the danger of the disease return
- post-menopausal women diagnosed with high-stage or metastatic hormone-receptor-positive mamar growth
Women must not taking tamoxifen when they start taking this medication.
These tabs will not work on hormone-receptor-negative breast tumor.
This medication is a pill used once daily. Mainly of doctors given using this medication in time all day.
This drug is given for supplementary healing of postmenopausal women with estrogenreceptor positive early breast tumor who have taken in 2-3 years of tamoxifen and are changed to Exedrol (Exemestane) for achievement of a total of five repeated years of help hormonal cure.
Exedrol (Exemestane) is prescribed for the management of complex breast growth in postmenopausal women whose disease has developed next tamoxifen therapy.
Prescribed to therapy:
- post-menopausal women diagnosed with hormone-receptor-positive, begin-stage breast tumor after they`ve taken tamoxifen for 2 to 3 years to diminish the danger of the disease return
- post-menopausal women diagnosed with high-stage or metastatic hormone-receptor-positive mamar growth
Women must not taking tamoxifen when they start taking this medication.
These tabs will not work on hormone-receptor-negative breast tumor.
This medication is a pill used once daily. Mainly of doctors given using this medication in time all day.
This drug is given for supplementary healing of postmenopausal women with estrogenreceptor positive early breast tumor who have taken in 2-3 years of tamoxifen and are changed to Exedrol (Exemestane) for achievement of a total of five repeated years of help hormonal cure.
Exedrol (Exemestane) is prescribed for the management of complex breast growth in postmenopausal women whose disease has developed next tamoxifen therapy.
How should Exedrol (Exemestane) be dosed?
The suggested dose of these tabs in early and later breast malignancy is one 25 mgtablet one tiem in day after a meal.
In postmenopausal patients with early breast cancer who have been treated with 2–3 years of tamoxifen, management with this preparation must go on in the nonexistence of recurrence or contra lateral breast malignancy until achievement of 5 years of adjuvant endocrine remedy.
For people with progressed breast disease, therapy with these tablets have to continue until disease evolution is clear.
For people taking in this drug with a forceful CYP 3A4 inducer such as rifampicin or phenytoin, the optional quantity of these tabs is 50 mg one time a day after food.
The suggested dose of these tabs in early and later breast malignancy is one 25 mgtablet one tiem in day after a meal.
In postmenopausal patients with early breast cancer who have been treated with 2–3 years of tamoxifen, management with this preparation must go on in the nonexistence of recurrence or contra lateral breast malignancy until achievement of 5 years of adjuvant endocrine remedy.
For people with progressed breast disease, therapy with these tablets have to continue until disease evolution is clear.
For people taking in this drug with a forceful CYP 3A4 inducer such as rifampicin or phenytoin, the optional quantity of these tabs is 50 mg one time a day after food.
Exedrol (Exemestane) - Undesirable Responses:
Boiling flashes, speedy breathing, painful joints and muscles, headache, atypical sweating, weight achieving, vomiting, diarrhea, tiredness, vertigo, difficult sleeping, and queasiness can happen.
Boiling flashes, speedy breathing, painful joints and muscles, headache, atypical sweating, weight achieving, vomiting, diarrhea, tiredness, vertigo, difficult sleeping, and queasiness can happen.